Welcome to our dedicated page for American Oncology Network news (Ticker: AONC), a resource for investors and traders seeking the latest updates and insights on American Oncology Network stock.
American Oncology Network (AONC) delivers physician-led oncology care through a nationwide network of independent practices focused on value-based treatment models. This page provides investors and healthcare stakeholders with timely updates on AONC's operational milestones, financial performance, and community impact.
Access official press releases and curated news covering strategic partnerships, technology integrations like AI-driven diagnostics, and expansions improving cancer care accessibility. Key updates include practice acquisitions, clinical trial advancements, and financial results demonstrating AONC's role in reshaping community oncology.
Bookmark this page for centralized access to AONC's evolving initiatives in care coordination, cost-effective treatment solutions, and partnerships addressing healthcare disparities. Stay informed through verified updates that reflect the network's commitment to operational excellence and patient-centered innovation.
MidAmerica Cancer Care (MACC) has opened a new medical oncology clinic in Kansas City, Kansas at 8919 Parallel Pkwy. The facility features private exam rooms, an infusion room, in-house lab and pathology services, and a specialty pharmacy for oral oncolytics.
The clinic is staffed by board-certified medical oncologists Jaswinder Singh, MD, Nicholas Shuler, DO, Shajadi Patan, MD, and Benjamin Fangman, MD. As a community-based practice, MACC provides affordable cancer care across the Kansas City Metropolitan area and western Missouri.
This expansion follows MACC's recent partnership with American Oncology Network (AON) announced in January, enhancing their service offerings including access to in-house specialty pharmacy with home delivery of certain medications.
Woodlands Cancer Institute, a partner practice of American Oncology Network (AON), has relocated its medical oncology clinic in The Woodlands, Texas to 18354 I-45 South, Suite 200. The new facility features enhanced amenities including additional private exam rooms, an infusion room, in-house lab and pathology services, and a specialty pharmacy for oral oncolytics.
Board-certified medical oncologists Dr. Eric P. Kleinbaum, Dr. Sandeep Kodityal, and Dr. Krishna K. Pachipala are now accepting patients at the new location. The practice's radiation oncology services will remain at 135 Vision Park Blvd., while the Conroe clinic continues operations at 603 Conroe Medical Drive.
The relocation aims to expand patient services and therapeutics while providing larger space for additional staff. As a community-based practice partnered with AON, Woodlands Cancer Institute offers affordable, personalized cancer care with access to in-house specialty pharmacy services including home medication delivery.
American Oncology Network (AON) has launched LabVizor (LV), an advanced cloud-based anatomic pathology laboratory information system developed by SigmaCore. This HIPAA-compliant system, designed specifically for oncologists and pathologists, integrates complex pathology reports into a streamlined, comprehensive system.
LabVizor is the result of over 12 years of development by industry experts, including hematopathologist Dr. Aamir Ehsan and Atiq Malik, Executive Vice President of IT at SigmaCore. The platform is fully integrated with AON's electronic medical record system, enabling bidirectional data exchange.
Key features include:
- Pre-Accessioning for improved workflow planning
- Integrated Reporting of complex diagnostic information
- User-Friendly Dashboard with comprehensive lab operations view
- Data Analytics supporting clinical guidelines
- Collaboration Tools for effective workflow management
This integration aligns with AON's mission to provide efficient, high-quality oncology services and improve patient care.
Florida Oncology and Hematology (FOH), a partner practice of American Oncology Network (AON), has announced the addition of Dr. Michele Ramirez to their physician team. Dr. Ramirez, a Board-certified medical oncologist and hematologist with over 20 years of experience, will be accepting patients at Naples Community Hospital Baker Hospital Downtown and Naples Community Hospital North Naples Hospital.
Dr. Ramirez earned her medical degree from Cornell University Medical College and completed her residency and fellowship at Case Western Reserve University. She joins FOH's team of eight medical oncologists and 10 advanced practice providers across five Florida locations. The practice offers comprehensive cancer care services including diagnosis, treatment, clinical trials, survivorship, and patient support, all conveniently located close to patients' homes.
MidAmerica Cancer Care (MACC) has joined American Oncology Network (AON), marking a significant expansion in community-based oncology services. MACC, established in 2019, serves the Kansas City metropolitan area and western Missouri with six Board-certified medical oncologists and 16 advanced practitioners.
The partnership aims to enhance MACC's service offerings, including expanded clinical trials and new market opportunities, while maintaining their patient-centered approach. MACC provides comprehensive cancer care services, including diagnostics, treatment, clinical trials, and survivorship programs, featuring private exam rooms and on-site infusion suites.
This collaboration aligns with AON's mission to expand access to high-quality cancer care in local communities and demonstrates their ability to work with both physician groups and hospital systems. The partnership will enable MACC to leverage AON's resources while continuing to deliver personalized cancer care in a community setting.
Florida Oncology and Hematology, a partner practice of American Oncology Network (AON), has relocated its Fort Myers clinic to 14551 Hope Center Loop. The new state-of-the-art facility features 12 exam rooms, nearly 30 infusion chairs, and an onsite lab.
The expanded clinic provides enhanced services including private exam rooms for patient-physician consultations, infusion services, in-house lab and pathology services, and an onsite specialty pharmacy for oral oncolytics. Board-certified medical oncologists Dr. Magali Van den Bergh, Dr. Venkata Parsa, and Dr. Shivtaj Mann are accepting patients at the new location.
The practice serves patients in Cape Coral, Clearwater, Fort Myers, Naples, and surrounding areas across five clinic locations, offering community-based, affordable cancer care in a comfortable environment with state-of-the-art treatments.
American Oncology Network (AON) has appointed Charlie Goddard as General Counsel. Goddard brings over 15 years of legal experience in healthcare law, corporate governance, and compliance, with expertise in fraud and abuse prevention, data privacy, cyber security, dispute resolution, and high-stakes commercial transactions.
Prior to joining AON, Goddard worked at an AmLaw 100 firm and served as general counsel for a leading orthopedic surgery group. He is a graduate of Florida State University College of Law and is licensed to practice in Florida state courts and the U.S. District Court for the Middle District of Florida.
AON's CEO Todd Schonherz and Chief Medical Officer Dr. Stephen Divers expressed confidence that Goddard's healthcare expertise will help navigate complexities while advancing strategic initiatives as the company continues its growth as one of the nation's fastest-growing community oncology networks.
Fort Wayne Medical Oncology and Hematology (FWMOH), established in 1977, has joined the American Oncology Network (AON), a rapidly growing network of community-based oncology practices.
This partnership will enable FWMOH to expand its patient-focused services and continue providing high-quality, compassionate care. Dr. Praveen Kollipara, president of FWMOH, highlighted that this collaboration comes at an exciting time as FWMOH has recently added leading gynecologic oncologists and expanded its presence in Peru and Warsaw.
FWMOH operates nine locations across northeastern Indiana with 16 Board-certified medical oncologists and two Board-certified gynecologic oncologists, Dr. Iwona Podzielinski and Dr. Scott Goodrich. Dr. Podzielinski emphasized that this partnership will strengthen their ability to offer cutting-edge treatments while maintaining a patient-centered approach.
FWMOH provides comprehensive cancer care services, including laboratory services, PET/CT imaging, oral and IV infusion treatments, clinical trials, survivorship programs, and patient support. The clinics feature private exam rooms and on-site infusion suites for patient comfort.
AON’s CEO, Todd Schonherz, and CMO, Stephen Fred Divers, MD, expressed their excitement about the partnership, noting the alignment with AON’s mission to expand access to high-quality, patient-first cancer care nationwide.
Cancer and Blood Specialists of Arizona (CBSA), a partner practice of American Oncology Network (AONC), announces the addition of Dr. Ronak Rakesh Shah to its physician care team at the Casa Grande clinic. Dr. Shah, a Board-certified medical oncologist and hematologist, brings expertise from his education at Michigan State University and fellowship training at Larkin Community Hospital.
CBSA's team now comprises two medical oncologists, a radiation oncologist, a general surgeon, and three advanced practice providers across two Arizona locations. The practice offers comprehensive cancer care services including diagnosis, treatment, clinical trials, survivorship, and patient support, all accessible locally to minimize patient travel.
American Oncology Network (AON) has partnered with Vantage Health Technologies to enhance cancer care delivery through an AI-enabled value-based care platform. The collaboration will initially implement Vantage's SocialHealth360 solution to improve patient navigation and address Social Determinants of Health (SDoH). The platform is expected to save healthcare professionals 5-8 hours weekly on administrative tasks, reduce provider burnout, and improve patient outcomes while lowering care costs. Future phases will focus on implementing AI solutions for value-based care use-cases.